What Are "Glow" Peptides? GHK-Cu and the Skin-Cell Research
The peptide behind most "glow" formulas is GHK-Cu, glycyl-L-histidyl-L-lysine bound to copper. It occurs naturally in human plasma, and in cultured skin cells it raises collagen and glycosaminoglycan output while lowering inflammatory signaling. This research-use-only reference traces what the in-vitro and animal literature actually shows, and where the human evidence stops.
Research-use-only disclaimer: GHK-Cu supplied as a research chemical is intended strictly for in-vitro and laboratory research use and is not intended for human, cosmetic, or veterinary use in that context. Every finding below is drawn from cell-culture or animal models and is described in hedged, mechanistic terms. Nothing here is medical advice.
TL;DR
GHK-Cu (glycyl-L-histidyl-L-lysine plus Cu2+) is a naturally occurring tripeptide first isolated from human plasma by Pickart in 1973. In cultured fibroblasts it raises collagen (types I and III) and glycosaminoglycan synthesis at nanomolar to low-micromolar concentrations, shifts the MMP/TIMP balance toward matrix building, and lowers inflammatory cytokines. Most evidence is in vitro or in animal wounds; controlled human "glow" data is limited. Research use only.
Structure: tripeptide Gly-His-Lys complexed 1:1 with copper(II); the bound copper is essential for activity.
Fibroblasts: raises type I and III collagen and glycosaminoglycan synthesis at nanomolar to low-micromolar doses.
Matrix: shifts MMP/TIMP balance toward remodeling; increases decorin and proteoglycans.
Inflammation: lowers reported TNF-alpha and IL-6 in these models.
Status: strong in-vitro and animal evidence; limited controlled human data. Research use only.
What Is GHK-Cu and How Is It Structured?
GHK-Cu is a copper-binding tripeptide, glycine-histidine-lysine complexed one-to-one with copper(II). Loren Pickart isolated the GHK sequence from human plasma albumin in 1973 and later showed it also appears in saliva and urine. Its concentration in human plasma falls with age, from roughly 200 ng/mL near age 20 to about 80 ng/mL by age 60, which is one reason it is studied in skin-aging and repair models.
The molecule is small, three amino acids, and its activity depends on the bound copper, a cofactor many skin enzymes require. That pairing, a carrier peptide plus a metal ion, is what separates GHK-Cu from a plain copper salt and from copper-free signal peptides. PrymaLab also studies GHK-Cu inside blends such as the GKP research blend (GHK-Cu, BPC-157, KPV).
What Does GHK-Cu Do to Skin Cells in the Lab?
In cultured human dermal fibroblasts, GHK-Cu increases synthesis of collagen and glycosaminoglycans at nanomolar to low-micromolar concentrations. Reported effects include higher production of type I and type III collagen, more decorin and proteoglycans, and increased secretion of the matrix components that give skin its structure, as summarized by Pickart & Margolina (2018).
Because activity shows up at very low concentrations, GHK-Cu reads in the literature as a signaling molecule rather than a bulk nutrient: it appears to instruct fibroblasts, not simply feed them copper. [INSERT PRYMALAB DATA: analytical detail for your GHK-Cu reference material, e.g. "Our GHK-Cu reference lots test at ≥99% by HPLC with mass confirmed by LC-MS; see the linked COA." Use a real lot number and figure.]
How Does GHK-Cu Affect Collagen and the Skin Matrix?
Research points to two connected mechanisms. First, GHK-Cu shifts the balance of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), the enzymes that remodel the collagen scaffold, described in the glycosaminoglycan and proteoglycan work of Maquart and colleagues. Second, it lowers inflammatory signaling in these models, with reported drops in cytokines such as TNF-alpha and IL-6. Together those changes describe an environment in which cultured cells rebuild matrix rather than break it down.
What Genes Does GHK-Cu Influence?
A 2018 gene-expression analysis by Pickart & Margolina reported that GHK can shift expression of a large fraction of assayed human genes, including collagen, antioxidant, and DNA-repair pathways. Treat the "roughly one-third of the genome" figure as a screening-level result from cell studies, not a proven clinical outcome. It tells researchers where to look, not what happens on a person's face.
GHK-Cu vs. Copper Salts vs. Other "Glow" Peptides
| Compound | What research studies show | Main model |
|---|---|---|
| GHK-Cu (copper tripeptide) | Collagen and GAG synthesis, MMP/TIMP modulation, anti-inflammatory signaling | Cultured fibroblasts; animal wounds |
| Copper salt alone | Supplies copper but lacks the peptide carrier that targets and regulates delivery | Biochemical assays |
| Pal-AHK (AHK-Cu) | Sibling copper tripeptide; studied for follicle and fibroblast signaling (see video below) | Dermal papilla cells; fibroblasts |
| Copper-free matrikines (e.g. Pal-KTTKS) | Signal collagen synthesis without a metal cofactor; a different pathway | Fibroblast culture |
Related Research Video: Copper Peptides in Skin Cells
GHK-Cu has a close structural sibling, Pal-AHK (AHK-Cu), which coordinates copper through the same histidine chemistry. This PrymaLab research overview walks through copper-peptide signaling in dermal papilla and fibroblast models, useful context for the GHK-Cu matrix story above.
Copper-peptide signaling in skin and follicle cells (PrymaLab). Research use only.
What Has Research NOT Established?
Most of the strong GHK-Cu data sits in cell culture and animal wounds. Controlled human trials for cosmetic "glow" or anti-aging claims are smaller and fewer, so the jump from a fibroblast dish to visible skin change is not settled science. Copper dose and formulation also matter: more copper is not automatically better, and stability in a finished product is its own variable. For a research audience, GHK-Cu is a well-characterized tool compound with strong in-vitro evidence and open human questions.
How is research-grade GHK-Cu characterized?
Because GHK-Cu activity depends on the intact copper complex, identity and purity verification matter for reproducible cell studies. Research-grade GHK-Cu is typically confirmed by reversed-phase HPLC for purity and mass spectrometry for identity, with attention to copper-complex consistency, and supplied for laboratory use only. At PrymaLab, research peptides are characterized with HPLC/MS verification and independent third-party testing. No specific lot data are asserted in this general reference.
Frequently Asked Questions
Is GHK-Cu the same as the "glow" blend?
"Glow" is a formula name. The active copper peptide in most such products is GHK-Cu, sometimes combined with other matrikine peptides. This reference covers the GHK-Cu research specifically.
What concentrations are used in GHK-Cu studies?
Fibroblast studies commonly report activity in the nanomolar to low-micromolar range. Exact concentrations vary by model and are set by the researcher.
How do GHK and AHK copper peptides differ?
Both coordinate copper through histidine; GHK uses glycine where AHK uses alanine. Their similarity is why AHK is studied for GHK-like collagen and growth-factor effects.
Is GHK-Cu approved for human use?
No. GHK-Cu reference material is sold and studied for laboratory research only. It is not a drug, cosmetic, or treatment.
References
- Pickart L, Margolina A. Skin Regenerative and Anti-Cancer Actions of Copper Peptides. Cosmetics. 2018;5(2):29. MDPI
- Maquart FX, et al. Modulation of glycosaminoglycan and proteoglycan synthesis by the tripeptide-copper complex GHK-Cu. J Invest Dermatol. ScienceDirect
- Pollard JD, et al. Effects of copper tripeptide on the growth and expression of growth factors in normal and irradiated fibroblasts. Arch Facial Plast Surg. 2005;7(1):27–31. Journal
- Tripeptides in wound healing and skin regeneration: a review. Int J Med Sci. 2025. Journal
Final disclaimer: This article is an educational research reference. GHK-Cu is sold and studied for laboratory research use only and is not approved by any regulatory authority for human, cosmetic, or veterinary use. Statements have not been evaluated by the FDA for the research-chemical context. Nothing here should be interpreted as medical or cosmetic advice.
Mechanistic descriptions are observations from cell and animal models that may not generalize. Always verify the legal status of any research compound in your jurisdiction before purchase or use.
